<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39240417</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-024-02386-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A considerable number of patients who contracted SARS-CoV-2 are affected by persistent multi-systemic symptoms, referred to as Post-COVID Condition (PCC). Post-exertional malaise (PEM) has been recognized as one of the most frequent manifestations of PCC and is a diagnostic criterion of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Yet, its underlying pathomechanisms remain poorly elucidated.</AbstractText><AbstractText Label="PURPOSE AND METHODS" NlmCategory="OBJECTIVE">In this review, we describe current evidence indicating that key pathophysiological features of PCC and ME/CFS are involved in physical activity-induced PEM.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Upon physical activity, affected patients exhibit a reduced systemic oxygen extraction and oxidative phosphorylation capacity. Accumulating evidence suggests that these are mediated by dysfunctions in mitochondrial capacities and microcirculation that are maintained by latent immune activation, conjointly impairing peripheral bioenergetics. Aggravating deficits in tissue perfusion and oxygen utilization during activities cause exertional intolerance that are frequently accompanied by tachycardia, dyspnea, early cessation of activity and elicit downstream metabolic effects. The accumulation of molecules such as lactate, reactive oxygen species or prostaglandins might trigger local and systemic immune activation. Subsequent intensification of bioenergetic inflexibilities, muscular ionic disturbances and modulation of central nervous system functions can lead to an exacerbation of existing pathologies and symptoms.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haunhorst</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4819-3513</Identifier><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, W&#xf6;llnitzer Stra&#xdf;e 42, 07749, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Interdisciplinary Prevention of Diseases Related to Professional Activities, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudziak</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Jena University Hospital/ Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheibenbogen</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt Universit&#xe4;t Zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifert</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6372-9769</Identifier><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt Universit&#xe4;t Zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotzny</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt Universit&#xe4;t Zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t Zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrends</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Children's Hospital, School of Medicine, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AGV Research Unit Gene Vectors, Helmholtz Munich (HMGU), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aden</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine I, Kiel University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, Kiel University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brockmann</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center Synergy of Systems, TU Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burggraf</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>mHealth Pioneers GmbH, K&#xf6;rtestra&#xdf;e 10, 10967, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>Wilhelm</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellert</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>, Landarztnetz Lahn-Dill, Wetzlar, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Initiative Long COVID Deutschland, Lemgo, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramoji</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Member of the Leibniz Centre for Photonics in Infection Research (LPI), Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Juergen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Member of the Leibniz Centre for Photonics in Infection Research (LPI), Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuken</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7696-475X</Identifier><AffiliationInfo><Affiliation>Department for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena Center for Mental Health, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Mental Health (DZPG), Partner Site Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallmach</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3936-4605</Identifier><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, W&#xf6;llnitzer Stra&#xdf;e 42, 07749, Jena, Germany. christian.puta@uni-jena.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany. christian.puta@uni-jena.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany. christian.puta@uni-jena.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">Physical activity</Keyword><Keyword MajorTopicYN="N">Post COVID condition</Keyword><Keyword MajorTopicYN="N">Post-exertional malaise</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39240417</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02386-8</ArticleId><ArticleId IdType="pii">10.1007/s15010-024-02386-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;6:100122.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WCCDWG on P-C-19. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2021;S1473&#x2013;3099:00703&#x2013;9.</Citation></Reference><Reference><Citation>Adjaye-Gbewonyo D, Vahratian A, Perrine CG, Bertolli J. Long COVID in Adults: United States, 2022. NCHS Data Briefs No 480. 2023.</Citation></Reference><Reference><Citation>Appel KS, N&#xfc;rnberger C, Bahmer T, F&#xf6;rster C, Polidori MC, Kohls M, et al. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection. 2024;1&#x2013;17.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">34167876</ArticleId><ArticleId IdType="pmc">8206636</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Int J Environ Res Public Heal. 2023;20:1613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xe8;nech-Montoliu S, Puig-Barber&#xe1; J, Badenes-Marques G, Gil-Fortu&#xf1;o M, Orrico-S&#xe1;nchez A, Pac-Sa MR, et al. Long COVID prevalence and the impact of the third SARS-CoV-2 vaccine dose: a cross-sectional analysis from the third follow-up of the Borriana Cohort, Valencia, Spain (2020&#x2013;2022). 2023.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36587841</ArticleId><ArticleId IdType="pmc">9800016</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Guan Y, Liao Q, Ma Z, Zhang L, Dong J, et al. Long-term sequelae of different COVID-19 variants: the original strain versus the Omicron variant. Global Heal Medicine. 2022;4:322&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.35772/ghm.2022.01069</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">35717982</ArticleId><ArticleId IdType="pmc">9212672</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopff SM, Appel KS, Miljukov O, Schneider J, Addo MM, Bals R, et al. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron&#x2014;results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP). Infection. 2024. https://doi.org/10.1007/s15010-024-02270-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02270-5</ArticleId><ArticleId IdType="pubmed">38700656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Torres-Macho J, Catahay JA, Macasaet R, Velasco JV, Macapagal S, et al. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 2024;52:43&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">38113020</ArticleId><ArticleId IdType="doi">10.1007/s15010-023-02154-0</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis Official Publ Infect Dis Soc Am. 2021;74:1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019.</Citation></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. eClinicalMedicine. 2022;53:101651.</Citation><ArticleIdList><ArticleId IdType="pubmed">36133318</ArticleId><ArticleId IdType="pmc">9482331</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzp&#xf6;tter K, et al. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine. 2024;69:102456.</Citation><ArticleIdList><ArticleId IdType="pubmed">38333368</ArticleId><ArticleId IdType="pmc">10847699</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102456</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther 2022.</Citation></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics. 2018;8:66.</Citation><ArticleIdList><ArticleId IdType="pubmed">30208578</ArticleId><ArticleId IdType="pmc">6165517</ArticleId><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and post-exertional malaise among patients with long COVID. Neurol Int. 2022;15:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36648965</ArticleId><ArticleId IdType="pmc">9844405</ArticleId><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747.</Citation><ArticleIdList><ArticleId IdType="pubmed">36908615</ArticleId><ArticleId IdType="pmc">9998690</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Besteher B, Finke K, Fischer A, Holl A, Katzer K, et al. Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study. Eur Arch Psychiatry Clin Neurosci. 2023. https://doi.org/10.1007/s00406-023-01661-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01661-3</ArticleId><ArticleId IdType="pubmed">37587244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:5104.</Citation><ArticleIdList><ArticleId IdType="pubmed">36042189</ArticleId><ArticleId IdType="pmc">9426365</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger ER, Lin J-MS, Wisk LE, Yu H, L&#x2019;Hommedieu M, Lavretsky H, et al. Myalgic encephalomyelitis/chronic fatigue syndrome after SARS-CoV-2 infection. JAMA Netw Open. 2024;7:e2423555.</Citation></Reference><Reference><Citation>Hartle M, Bateman L, Vernon SD. Dissecting the nature of post-exertional malaise. Fatigue Biomed Heal Behav. 2021;9:1&#x2013;12.</Citation></Reference><Reference><Citation>Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of post-exertional malaise (PEM) in patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS): a patient-driven survey. Diagnostics. 2019;9:26.</Citation><ArticleIdList><ArticleId IdType="pubmed">30832336</ArticleId><ArticleId IdType="pmc">6468435</ArticleId><ArticleId IdType="doi">10.3390/diagnostics9010026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023;74:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: a patient-centered, cross-sectional survey. PLoS One. 2018;13: e0197811.</Citation><ArticleIdList><ArticleId IdType="pubmed">29856774</ArticleId><ArticleId IdType="pmc">5983853</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0197811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E-J, Kang E-B, Jang E-S, Son C-G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J Clin Med. 2020;9:4040.</Citation><ArticleIdList><ArticleId IdType="pubmed">33327624</ArticleId><ArticleId IdType="pmc">7765094</ArticleId><ArticleId IdType="doi">10.3390/jcm9124040</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel B, Kedor C, Grabowski P, Wittke K, Thiel S, Scherbakov N, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19:159.</Citation><ArticleIdList><ArticleId IdType="pubmed">33874961</ArticleId><ArticleId IdType="pmc">8056497</ArticleId><ArticleId IdType="doi">10.1186/s12967-021-02774-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold F, M&#xfc;ller P, Gronwald T, M&#xfc;ller NG. Dose-response matters! &#x2013; a perspective on the exercise prescription in exercise-cognition research. Front Psychol. 2019;10:2338.</Citation><ArticleIdList><ArticleId IdType="pubmed">31736815</ArticleId><ArticleId IdType="pmc">6839278</ArticleId><ArticleId IdType="doi">10.3389/fpsyg.2019.02338</ArticleId></ArticleIdList></Reference><Reference><Citation>Colosio M, Brocca L, Gatti M, Neri M, Crea E, Cadile F, et al. Structural and functional impairments of skeletal muscle in patients with post-acute sequelae of SARS-CoV-2 infection. J Appl Physiol. 2023. https://doi.org/10.1152/japplphysiol.00158.2023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00158.2023</ArticleId><ArticleId IdType="pubmed">38051270</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, Petrache I, Goldstein NM, Olin JT, Keith RC, Modena B, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Resp Crit Care. 2021;205:126&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58:2100870.</Citation><ArticleIdList><ArticleId IdType="pubmed">33926969</ArticleId><ArticleId IdType="pmc">8082950</ArticleId><ArticleId IdType="doi">10.1183/13993003.00870-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Skj&#xf8;rten I, Ankerstjerne OAW, Trebinjac D, Br&#xf8;nstad E, Rasch-Halvorsen &#xd8;, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58:2100996.</Citation><ArticleIdList><ArticleId IdType="pubmed">34210791</ArticleId><ArticleId IdType="pmc">8247555</ArticleId><ArticleId IdType="doi">10.1183/13993003.00996-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults. Jama Netw Open. 2022;5: e2236057.</Citation><ArticleIdList><ArticleId IdType="pubmed">36223120</ArticleId><ArticleId IdType="pmc">9557896</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J. 2021;58:2101763.</Citation><ArticleIdList><ArticleId IdType="pubmed">34244323</ArticleId><ArticleId IdType="pmc">8287735</ArticleId><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Singh I. Post-acute sequelae of SARS-CoV-2 more than deconditioning. Chest. 2023;164:583&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">37689472</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2023.03.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130:1470&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33764166</ArticleId><ArticleId IdType="pmc">8143785</ArticleId><ArticleId IdType="doi">10.1152/japplphysiol.00710.2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">35176758</ArticleId><ArticleId IdType="pmc">8903393</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremme Y, Derlien S, Katzer K, Reuken PA, Stallmach A, Lewejohann J-C, et al. Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography. Infection. 2023;51:1841&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">37322387</ArticleId><ArticleId IdType="pmc">10665229</ArticleId><ArticleId IdType="doi">10.1007/s15010-023-02062-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2021;161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">34389297</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Leitner BP, Wang Y, Zhang H, Joseph P, Lutchmansingh DD, et al. Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome. Pulm Circ. 2023;13: e12220.</Citation><ArticleIdList><ArticleId IdType="pubmed">37091121</ArticleId><ArticleId IdType="pmc">10113513</ArticleId><ArticleId IdType="doi">10.1002/pul2.12220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn PA, Joseph P, Heerdt PM, Singh I. Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance. ERJ Open Res. 2024;10:00714&#x2013;2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38348243</ArticleId><ArticleId IdType="pmc">10860209</ArticleId><ArticleId IdType="doi">10.1183/23120541.00714-2023</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Singh I, Oliveira R, Capone CA, Mullen MP, Cook DB, et al. Exercise pathophysiology in myalgic encephalomyelitis/chronic fatigue syndrome and postacute sequelae of SARS-CoV-2 more in common than not? Chest. 2023;164:717&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">37054777</ArticleId><ArticleId IdType="pmc">10088277</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2023.03.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15:17.</Citation><ArticleIdList><ArticleId IdType="pubmed">38177128</ArticleId><ArticleId IdType="pmc">10766651</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Wyler E, Baum O, Hentschel A, Legler F, Preusse C, et al. Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles. 2023;21:e68.</Citation></Reference><Reference><Citation>Bizjak DA, Ohmayer B, Buhl JL, Schneider EM, Walther P, Calzia E, et al. Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and Post-COVID syndrome. Int J Mol Sci. 2024;25:1675.</Citation><ArticleIdList><ArticleId IdType="pubmed">38338957</ArticleId><ArticleId IdType="pmc">10855807</ArticleId><ArticleId IdType="doi">10.3390/ijms25031675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, &#xd8;stergaard LJ, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29:2832&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">35661354</ArticleId><ArticleId IdType="doi">10.1111/ene.15435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Ma J, Kim Y-C, Son AY, Syed AM, Liu C, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci. 2023;120: e2302738120.</Citation><ArticleIdList><ArticleId IdType="pubmed">37579159</ArticleId><ArticleId IdType="pmc">10450651</ArticleId><ArticleId IdType="doi">10.1073/pnas.2302738120</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. 2022;12:1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">36355108</ArticleId><ArticleId IdType="pmc">9699059</ArticleId><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId></ArticleIdList></Reference><Reference><Citation>Helbing DL, Dommaschk E-M, Danyeli LV, Liepinsh E, Refisch A, Sen ZD, et al. Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review. Eur Arch Psychiatry Clin Neurosci. 2024. https://doi.org/10.1007/s00406-023-01734-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01734-3</ArticleId><ArticleId IdType="pubmed">38172332</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: In the cross fire of SARS-CoV-2 and immunity. Iscience. 2020;23: 101631.</Citation><ArticleIdList><ArticleId IdType="pubmed">33015593</ArticleId><ArticleId IdType="pmc">7524535</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2020.101631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer H, Teschler M, Mooren FC, Schmitz B. Altered tissue oxygenation in patients with post COVID-19 syndrome. Microvasc Res. 2023;148: 104551.</Citation><ArticleIdList><ArticleId IdType="pubmed">37201676</ArticleId><ArticleId IdType="pmc">10188192</ArticleId><ArticleId IdType="doi">10.1016/j.mvr.2023.104551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. New Engl J Med. 2020;383:120&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32437596</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Amor HIH, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Frontiers Cardiovasc Medicine. 2021;8: 745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID&#x2014;the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21:2020&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">37178769</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, et al. Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. 2024;52:1269&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">38324145</ArticleId><ArticleId IdType="pmc">11289012</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02173-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomed. 2021;9:957.</Citation></Reference><Reference><Citation>Ambrosino P, Parrella P, Formisano R, Perrotta G, D&#x2019;Anna SE, Mosella M, et al. Cardiopulmonary exercise performance and endothelial function in convalescent COVID-19 patients. J Clin Medicine. 2022;11:1452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051452</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N, Heightman M, Hillman T, Wall E, Bell R, Kessler A, et al. Impaired exercise capacity in post&#x2013;COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35543533</ArticleId><ArticleId IdType="pmc">9098525</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2021006944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien C, Heine J, Khalil A, Schlenker L, Hartung TJ, Boesl F, et al. Altered brain perfusion and oxygen levels relate to sleepiness and attention in post-COVID syndrome. Ann Clin Transl Neurol. 2024. https://doi.org/10.1002/acn3.52121 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.52121</ArticleId><ArticleId IdType="pubmed">38874398</ArticleId><ArticleId IdType="pmc">11330224</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Mon&#xe1;rrez-Espino J, L&#xf3;pez DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13:12420.</Citation><ArticleIdList><ArticleId IdType="pubmed">37528111</ArticleId><ArticleId IdType="pmc">10394026</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Gervasoni J, Picca A, Ciciarello F, Galluzzo V, Coelho-J&#xfa;nior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on l-arginine metabolism in adults with long COVID: secondary analysis of a randomized clinical trial. Int J Mol Sci. 2023;24:5078.</Citation><ArticleIdList><ArticleId IdType="pubmed">36982151</ArticleId><ArticleId IdType="pmc">10049539</ArticleId><ArticleId IdType="doi">10.3390/ijms24065078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinat R, Villalobos-Labra R, Hofmann L, Blauensteiner J, Sep&#xfa;lveda N, Westermeier F. Decreased no production in endothelial cells exposed to plasma from ME/CFS patients. Vasc Pharmacol. 2022;143: 106953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106953</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-J&#xfa;nior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with Long COVID: a single-blind randomized controlled trial. Nutrients. 2022;14:4984.</Citation><ArticleIdList><ArticleId IdType="pubmed">36501014</ArticleId><ArticleId IdType="pmc">9738241</ArticleId><ArticleId IdType="doi">10.3390/nu14234984</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Trimarco V, Mone P, Alo&#xe8; T, Marzani MC, Diana A, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: The LINCOLN survey. Pharmacol Res. 2022;183: 106360.</Citation><ArticleIdList><ArticleId IdType="pubmed">35868478</ArticleId><ArticleId IdType="pmc">9295384</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, et al. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. 2022;11:2376.</Citation><ArticleIdList><ArticleId IdType="pubmed">35954219</ArticleId><ArticleId IdType="pmc">9367589</ArticleId><ArticleId IdType="doi">10.3390/cells11152376</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Wyler E, Baum O, Hentschel A, Rust R, Legler F, et al. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol Commun. 2023;11:193.</Citation><ArticleIdList><ArticleId IdType="pubmed">38066589</ArticleId><ArticleId IdType="pmc">10704838</ArticleId><ArticleId IdType="doi">10.1186/s40478-023-01662-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">37080828</ArticleId><ArticleId IdType="pmc">10113134</ArticleId><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pubmed">34425843</ArticleId><ArticleId IdType="pmc">8381139</ArticleId><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A, Kessler A, de Groot R, Dragunaite B, Heightman M, Hillman T, et al. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J Thromb Haemost. 2023;21:94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">36695401</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2022.10.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, Glass KA, Germain A, Franconi CJ, Zhang S, Hanson MR. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. J Extracell Vesicles. 2024;13:12403.</Citation><ArticleIdList><ArticleId IdType="pubmed">38173127</ArticleId><ArticleId IdType="pmc">10764978</ArticleId><ArticleId IdType="doi">10.1002/jev2.12403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, L&#xf6;hn M. Microvascular capillary and precapillary cardiovascular disturbances strongly interact to severely affect tissue perfusion and mitochondrial function in myalgic encephalomyelitis/chronic fatigue syndrome evolving from the post COVID-19 syndrome. Medicina. 2024;60:194.</Citation><ArticleIdList><ArticleId IdType="pubmed">38399482</ArticleId><ArticleId IdType="pmc">10890404</ArticleId><ArticleId IdType="doi">10.3390/medicina60020194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. The potential role of ischaemia&#x2013;reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022;479:1653&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">36043493</ArticleId><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris KI, Nella AA, Zhu Z, Swanson SA, Casale GP, Gutti TL, et al. Mitochondriopathy of peripheral arterial disease. Vascular. 2007;15:336&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">18053417</ArticleId><ArticleId IdType="doi">10.2310/6670.2007.00054</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau M, Ibershoff L, Zacher J, Bros J, Tomschi F, Diebold KF, et al. Even patients with mild COVID-19 symptoms after SARS-CoV-2 infection show prolonged altered red blood cell morphology and rheological parameters. J Cell Mol Med. 2022. https://doi.org/10.1111/jcmm.17320 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17320</ArticleId><ArticleId IdType="pubmed">35419946</ArticleId><ArticleId IdType="pmc">9097836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kell DB, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a role for viruses. Blood Rev. 2023;60: 101075.</Citation><ArticleIdList><ArticleId IdType="pubmed">36963989</ArticleId><ArticleId IdType="pmc">10027292</ArticleId><ArticleId IdType="doi">10.1016/j.blre.2023.101075</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ning D, Kuebler WM, Vogel D, Bloch W. The oxygen dissociation curve of blood in COVID-19&#x2013;an update. Front Med. 2023;10:1098547.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1098547</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577778</ArticleId><ArticleId IdType="pmc">8727854</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome &#x2013; evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajloun Z, Khattar ZA, Kovacic H, Legros C, Sabatier J-M. Why do athletes develop very severe or fatal forms of COVID after intense exercise following SARS-CoV-2 infection or anti-COVID vaccination? Infect Disord - Drug Targets. 2023;23:E110123212563.</Citation><ArticleIdList><ArticleId IdType="pubmed">36631923</ArticleId><ArticleId IdType="doi">10.2174/1871526523666230111104355</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881-895.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">35216672</ArticleId><ArticleId IdType="pmc">8786632</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Sarkar S, Fram. TR, Boppana S, Sterrett S, Qin K, et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. JCI Insight. 2021.</Citation></Reference><Reference><Citation>Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, BioResource N, et al. Spontaneous, persistent, T cell&#x2013;dependent IFN-&#x3b3; release in patients who progress to Long Covid. Sci Adv. 2024;10:eadie379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adi9379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Gr&#xfc;ner E, Pleimelding C, et al. Persistent immune abnormalities discriminate post-COVID syndrome from convalescence. Infection. 2024;52:1087&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">38326527</ArticleId><ArticleId IdType="pmc">11142964</ArticleId><ArticleId IdType="doi">10.1007/s15010-023-02164-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Pink I, Hennigs JK, Ruhl L, Sauer A, Boblitz L, Huwe M, et al. Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19. Infection. 2024;52:513&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">37924472</ArticleId><ArticleId IdType="doi">10.1007/s15010-023-02114-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin M-G, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25:218&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">38212464</ArticleId><ArticleId IdType="pmc">10834368</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2022;76:e487&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">10169416</ArticleId><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J M&#xe9;d Virol. 2023;95: e28568.</Citation><ArticleIdList><ArticleId IdType="pubmed">36756925</ArticleId><ArticleId IdType="pmc">10048846</ArticleId><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S, Bloch W, Wagner H, Ellert C, Kr&#xfc;ger K, Vilser DC, et al. Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 2022;3:iqac006.</Citation><ArticleIdList><ArticleId IdType="pubmed">36846561</ArticleId><ArticleId IdType="pmc">9494493</ArticleId><ArticleId IdType="doi">10.1093/oxfimm/iqac006</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, et al. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines. 2023;8:145.</Citation><ArticleIdList><ArticleId IdType="pubmed">37773184</ArticleId><ArticleId IdType="pmc">10541897</ArticleId><ArticleId IdType="doi">10.1038/s41541-023-00739-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">10620090</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. 2020;21:1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">32041178</ArticleId><ArticleId IdType="pmc">7036826</ArticleId><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Elson JL, Strassheim V, Newton JL, Walker M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS One. 2020;15: e0231136.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275686</ArticleId><ArticleId IdType="pmc">7147788</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0231136</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Sanislav O, Allan CY, Smith PK, Annesley SJ, Fisher PR. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int J Mol Sci. 2021;22:2046.</Citation><ArticleIdList><ArticleId IdType="pubmed">33669532</ArticleId><ArticleId IdType="pmc">7921983</ArticleId><ArticleId IdType="doi">10.3390/ijms22042046</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya J, Leddy SM, Gottschalk CG, Peterson DL, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. 2023;24:2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">36768336</ArticleId><ArticleId IdType="pmc">9916395</ArticleId><ArticleId IdType="doi">10.3390/ijms24032010</ArticleId></ArticleIdList></Reference><Reference><Citation>Raizen DM, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, et al. Beyond the symptom: the biology of fatigue. Sleep. 2023;46:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsad069</ArticleId></ArticleIdList></Reference><Reference><Citation>Villacampa A, Alfaro E, Morales C, D&#xed;az-Garc&#xed;a E, L&#xf3;pez-Fern&#xe1;ndez C, Bartha JL, et al. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal. 2024;22:38.</Citation><ArticleIdList><ArticleId IdType="pubmed">38225643</ArticleId><ArticleId IdType="pmc">10788971</ArticleId><ArticleId IdType="doi">10.1186/s12964-023-01397-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano AC, Camargo LL, Mary S, Neves KB, Rios FJ, Stein R, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13:14086.</Citation><ArticleIdList><ArticleId IdType="pubmed">37640791</ArticleId><ArticleId IdType="pmc">10462711</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-41115-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. 2021. Biosci Rep. https://doi.org/10.1042/BSR20210611 .</Citation></Reference><Reference><Citation>Scheppke KA, Pepe PE, Jui J, Crowe RP, Scheppke EK, Klimas NG, et al. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research. Am J Emerg Med. 2024;75:122&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37944296</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2023.09.051</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezhnoy G, Bissinger R, Liu A, Cannet C, Sch&#xe4;fer H, Kienzle K, et al. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients. Front Immunol. 2023;14:1144224.</Citation><ArticleIdList><ArticleId IdType="pubmed">37228606</ArticleId><ArticleId IdType="pmc">10203989</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1144224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A, Lacout C, Ghali M, Gury A, Beucher A-B, Lozac&#x2019;h P, et al. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci Rep. 2019;9:18817.</Citation></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc National Acad Sci. 2021;118: e2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker M, Hall K, Peppercorn K, Tate W. The significance of oxidative stress in the pathophysiology of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). M&#xe9;d Res Arch. 2022;10.</Citation></Reference><Reference><Citation>McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018;125:15&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29601945</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.03.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S, Bloch W, Ringleb M, Fennen L, Wagner H, Gabriel HHW, et al. Acute effects of heavy resistance exercise on biomarkers of neuroendocrine-immune regulation in healthy adults: a systematic review. Exerc Immunol Rev. 2022;28:36&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">35452397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, et al. Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise &#x2013; a systematic review and meta-analysis. FASEB J. 2024;38: e23596.</Citation><ArticleIdList><ArticleId IdType="pubmed">38597350</ArticleId><ArticleId IdType="doi">10.1096/fj.202301619R</ArticleId></ArticleIdList></Reference><Reference><Citation>McManimen SL, Sunnquist ML, Jason LA. Deconstructing post-exertional malaise: an exploratory factor analysis. J Heal Psychol. 2019;24:188&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105316664139</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29:19&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557875</ArticleId><ArticleId IdType="doi">10.1007/s11011-013-9435-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Petter E, Scheibenbogen C, Linz P, Stehning C, Wirth K, Kuehne T, et al. Muscle sodium content in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2022;20:580.</Citation><ArticleIdList><ArticleId IdType="pubmed">36494667</ArticleId><ArticleId IdType="pmc">9733289</ArticleId><ArticleId IdType="doi">10.1186/s12967-022-03616-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2021;19:162.</Citation><ArticleIdList><ArticleId IdType="pubmed">33882940</ArticleId><ArticleId IdType="pmc">8058748</ArticleId><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O&#x2019;Keeffe E, Zaporojan L, et al. Blood&#x2013;brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">38388736</ArticleId><ArticleId IdType="pmc">10917679</ArticleId><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med. 2023;10:1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId></ArticleIdList></Reference><Reference><Citation>White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010;47:615&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">20230500</ArticleId><ArticleId IdType="pmc">4378647</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1&#x3b2;. Eur J Neurosci. 2022;56:5784&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">36153118</ArticleId><ArticleId IdType="doi">10.1111/ejn.15828</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;cary S, Gaboury I, Poirier S, Garcia C, Simpson S, Bull M, et al. Humility and acceptance: Working within our limits with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J Orthop Sport Phys. 2021;51:197&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2021.0106</ArticleId></ArticleIdList></Reference><Reference><Citation>Negro RWD, Turco P, Povero M. Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study. Multidiscip Respir Med. 2022;17:886.</Citation></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933347</ArticleId><ArticleId IdType="pmc">9356426</ArticleId><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein E, Heindrich C, Wittke K, Kedor C, Rust R, Freitag H, et al. Efficacy of repeat immunoadsorption in post-COVID ME/CFS patients with elevated &#x392;2-adrenergic receptor autoantibodies: a prospective cohort study. 2024.</Citation></Reference><Reference><Citation>Giszas B, Reuken PA, Katzer K, Kiehntopf M, Schmerler D, Rummler S, et al. Immunoadsorption to treat patients with severe post&#x2010;COVID syndrome. Ther Apher Dial. 2023.</Citation></Reference><Reference><Citation>Rigo S, Urechie V, Diedrich A, Okamoto LE, Biaggioni I, Shibao CA. Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome &#x2013; a case-control study. Bioelectron Med. 2023;9:19.</Citation><ArticleIdList><ArticleId IdType="pubmed">37670400</ArticleId><ArticleId IdType="pmc">10481607</ArticleId><ArticleId IdType="doi">10.1186/s42234-023-00121-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70:61&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PLoS One. 2020;15: e0240403.</Citation><ArticleIdList><ArticleId IdType="pubmed">33119613</ArticleId><ArticleId IdType="pmc">7595369</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0240403</ArticleId></ArticleIdList></Reference><Reference><Citation>Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400:359&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01109-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomed. 2021;9:1540.</Citation></Reference><Reference><Citation>Castro-Marrero J, Domingo JC, Cordobilla B, Ferrer R, Giralt M, Sanmart&#xed;n-Senta&#xf1;es R, et al. Does coenzyme Q10 plus selenium supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic encephalomyelitis/chronic fatigue syndrome? Antioxid Redox Signal. 2022;36:729&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">35229657</ArticleId><ArticleId IdType="pmc">9057907</ArticleId><ArticleId IdType="doi">10.1089/ars.2022.0018</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Senta&#xf1;es RS, Alegre-Martin J. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind. Placebo-Controlled Trial Nutrients. 2021;13:2658.</Citation><ArticleIdList><ArticleId IdType="pubmed">34444817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami S, Alavi SM, Daghagheleh R, Maraghi E, Hosseini SA. A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients. Virol J. 2024;21:91.</Citation><ArticleIdList><ArticleId IdType="pubmed">38654355</ArticleId><ArticleId IdType="pmc">11040844</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02362-6</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>